SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-026517
Filing Date
2021-05-14
Accepted
2021-05-14 17:09:50
Documents
4
Period of Report
2021-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea140936-8k_gxacquisit.htm 8-K 47728
2 LETTER AGREEMENT BY AND AMONG GX ACQUISITION CORP., ALPHA FIRST MERGER SUB, INC. ea140936ex2-1_gxacquisit.htm EX-2.1 20416
3 AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF GX ACQUISITION ea140936ex3-1_gxacquisit.htm EX-3.1 10080
4 PRESS RELEASE ISSUED MAY 14, 2021 ea140936ex99-1_gxacquisit.htm EX-99.1 16668
  Complete submission text file 0001213900-21-026517.txt   96151
Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
GX Acquisition Corp. (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 21925901
SIC: 2834 Pharmaceutical Preparations